Optimizing Postpartum Outcomes Act of 2026
The Optimizing Postpartum Outcomes Act of 2026 would direct the Secretary of Health and Human Services to issue guidance within one year on Medicaid and CHIP coverage for certain pelvic health services during pregnancy and the postpartum period. The guidance would focus on covered pelvic floor examinations and pelvic health physical therapy, and would be required to include state best practices, financing options, technical assistance for state Medicaid agencies, and suggested terminology and diagnosis codes for identifying pelvic floor dysfunction and related disorders.
The bill also requires the Government Accountability Office to study gaps in coverage for postpartum pelvic health services and other postpartum care for women who received Medicaid during pregnancy. In addition, it creates a new public health education campaign within the Public Health Service Act, to be carried out by CDC in coordination with HRSA and other agencies, to train health professionals and educate postpartum women about pelvic floor exams and pelvic health physical therapy. The bill authorizes $2 million annually for fiscal years 2027 through 2031 to support the education campaign.
The bill would not directly mandate new Medicaid benefits nationwide, but it would shape state policy by requiring federal guidance on how states can cover pelvic health services under Medicaid and CHIP, including through state plan amendments or waivers. It would also encourage states to use financing tools, referral incentives, and coding practices that make pelvic floor care easier to identify and reimburse. The legislation would amend the Public Health Service Act to add a new CDC-led education program and would require a GAO report on coverage gaps affecting postpartum women and related services.
The available context suggests the bill is generally supportive and preventive in tone, with a focus on improving maternal health outcomes and access to postpartum care. Because there are no recorded committee transcripts or votes, there is no evidence of formal opposition or amendment debate in the provided materials. The bill’s framing around education, access, and evidence-based care indicates a policy approach likely to attract bipartisan interest in maternal health and women’s health services.
No specific points of contention are documented in the provided record. Potential areas of debate, based on the bill text, could include the scope of federal guidance versus state flexibility, whether Medicaid and CHIP should be used to expand coverage for pelvic health services, and the cost and implementation burden on state agencies. The bill’s definition of covered services, including internal examinations when clinically necessary, and its use of federal funds for outreach and training could also draw scrutiny from those concerned about program scope or appropriations.